Sentinel lymph node detection in early stage ovarian cancer: the primary experience in N. N. Blokhin national medical Research Center of Oncology

Author:

Tikhonovskaya M. N.1ORCID,Shevchuk A. S.2ORCID

Affiliation:

1. N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

2. N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Department of Oncology and Radiation Therapy, Faculty of Medicine, N. I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Abstract

Background. Surgical staging including pelvic and para-aortic lymphadenectomy is recommended in patients with clinical early-stage epithelial ovarian cancer. The therapeutic role of pelvic and para-aortic lymphadenectomy is still under debate, this procedure can increase risk of intra- and post-operative complications. using the sentinel lymph node (SLN) detection in early stage ovarian cancer in very promising and decreases the level of surgical damage. But nowadays the data on effectiveness, safety sensitivity and specificity of SLN are limited and the technique has to be standardized.Aim. To determine the feasibility of the SLN detection procedure using indocyanine green in early stage ovarian cancer.Materials and methods. four patients with clinical stage I epithelial ovarian cancer underwent SLN detection using indocyanine green. The tracer was injected into hilum of the ovary or ovarian ligament stumps in the case of previous adnexectomy. SLN were detected in infrared spectrum. Systemic retroperitoneal lymph node dissection of the pelvic and paraaortic areas was performed after SLN being removed. frozen section of was not performed in this study.Results. SLN were detected in paraaortic area in three of four patients. no one of patients had metastatic disease.Conclusion. The primary experience demonstrates SLN mapping of the ovary being feasible. Prospective study is required to evaluate sensitivity and specificity of SLn detection in early stage ovarian cancer.

Publisher

Publishing House ABV Press

Subject

General Medicine

Reference19 articles.

1. The state of oncological care for the population of Russia in 2020. Eds.: Kaprin A.D., Starinskiy V.V., Shakhzadova A.O. Moscow: MNIOI im. P.A. Herzen – branch of the NMIC of Radiology of Ministry of Health of Russia, 2021. 239 p.

2. Ovarian cancer/fallopian tube cancer/primary peritoneal cancer. Clinical recommendations of the Association of Oncologists of Russia. 2020. Available at: https://oncology-association.ru.

3. Colombo N., Sessa C., du Bois A. et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol 2019;30:672–705. DOI: 10.1093/annonc/mdz062

4. Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer National Comprehensive Cancer Network Guidelines Version 1.2022. Available at: https://www.nccn.org/guidelines.

5. Trimbos B., Timmers P., Pecorelli S. et al. Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Nat Can Inst 2010;102(13):982–7. DOI: 10.1093/jnci/djq149

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3